Skip to Main Content

Author Details

Andrea Schietinger
Memorial Sloan Kettering Cancer Center
2004
39
25
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38058126A replicating LCMV-based vaccine for the treatment of solid tumors.Mol Ther2024
37461721Intratumoral immune triads are required for adoptive T cell therapy-mediated elimination of solid tumors.bioRxiv2023
37553760GABA Regulates Electrical Activity and Tumor Initiation in Melanoma.Cancer Discov2023
34253904CD8<sup>+</sup> T cell differentiation and dysfunction in cancer.Nat Rev Immunol2022
35385296Ketohexokinase-mediated fructose metabolism is lost in hepatocellular carcinoma and can be leveraged for metabolic imaging.Sci Adv2022
36517593Ovarian cancer mutational processes drive site-specific immune evasion.Nature2022
35131877Noninvasive Imaging of CD4+ T Cells in Humanized Mice.Mol Cancer Ther2022
35013003Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma.Cancer Immunol Res2022
34935874TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion.J Exp Med2022
34847567An autoimmune stem-like CD8 T cell population drives type 1 diabetes.Nature2022
33320837An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection.J Clin Invest2021
33495310Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [<sup>64</sup>Cu]Cu-NOTA-anti-CD8 PET.Clin Cancer Res2021
33762733NASH limits anti-tumour surveillance in immunotherapy-treated HCC.Nature2021
34524864Ectopic activation of the miR-200c-EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy.Sci Transl Med2021
32929232Exercise and immunometabolic regulation in cancer.Nat Metab2020
32605691Mite Burden and Immunophenotypic Response to <i>Demodex musculi</i> in Swiss Webster, BALB/c, C57BL/6, and NSG Mice.Comp Med2020
31207604TOX is a critical regulator of tumour-specific T cell differentiation.Nature2019
31181510Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections.Curr Opin Immunol2019
30499773Rejection of immunogenic tumor clones is limited by clonal fraction.Elife2018
28067900Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity.Nat Med2017
28514453Chromatin states define tumour-specific T cell dysfunction and reprogramming.Nature2017
27521269Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.Immunity2016
26440701Beyond Genomics: Multidimensional Analysis of Cancer Therapy Resistance.Trends Immunol2015
24210163Tolerance and exhaustion: defining mechanisms of T cell dysfunction.Trends Immunol2014
23637340IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner.Proc Natl Acad Sci U S A2013
24482750Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer.Oncoimmunology2013
22374983Densely granulated murine NK cells eradicate large solid tumors.Cancer Res2012
23162754A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs).Oncoimmunology2012
22984076Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer.J Immunol2012
22267581Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state.Science2012
20331471Ribosomal versus non-ribosomal cellular antigens: factors determining efficiency of indirect presentation to CD4+ T cells.Immunology2010
20921286Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase.J Exp Med2010
20479270Antibody recognition of a unique tumor-specific glycopeptide antigen.Proc Natl Acad Sci U S A2010
18316622Equilibrium between host and cancer caused by effector T cells killing tumor stroma.Cancer Res2008
18518430Single-particle tunneling in strongly driven double-well potentials.Phys Rev Lett2008
18684640Specificity in cancer immunotherapy.Semin Immunol2008
17210731Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.J Exp Med2007
17038624A mutant chaperone converts a wild-type protein into a tumor-specific antigen.Science2006
14704792Priming of naive T cells inside tumors leads to eradication of established tumors.Nat Immunol2004
  • 1 - 39 of 39

Recommended Authors

Tiago da Silva Medina
International Research Center, A.C.Camargo Cancer Center
Career Start Year 2016
Number of shared co-authors 1
Ang Cui
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
Michel Enamorado
National Institute of Allergy and Infectious Diseases
Career Start Year 2013
Number of shared co-authors 0
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 0
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 1
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
Ansuman T Satpathy
Stanford University
Career Start Year 2005
Number of shared co-authors 0
Tori N Yamamoto
National Cancer Institute
Career Start Year 2005
Number of shared co-authors 0
Gavin P Dunn
Washington University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Suchit Jhunjhunwala
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 1
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 0
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 3
Evan F Lind
Oregon Health & Science University
Career Start Year 1999
Number of shared co-authors 0
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 1
Paola Cappello
University of Turin
Career Start Year 1998
Number of shared co-authors 0
Masaki Terabe
National Cancer Institute
Career Start Year 1997
Number of shared co-authors 0
Cynthia Perez
Loyola University Chicago
Career Start Year 1995
Number of shared co-authors 0
Chi Ma
Affiliated Yantai Yuhuangding Hospital of Qingdao University
Career Start Year 1995
Number of shared co-authors 0
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 7
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 0
Lawrence Fong
University of California san francisco
Career Start Year 1993
Number of shared co-authors 1
Firouzeh Korangy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 0
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Nir Hacohen
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 1
Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Career Start Year 1986
Number of shared co-authors 2
Sandra Demaria
Weill Cornell Medical College
Career Start Year 1985
Number of shared co-authors 4
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Career Start Year 1985
Number of shared co-authors 1
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 2
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 1

Collaborators

Paul Zumbo
Co-authored papers 4
Travis J Hollmann
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Agnes Viale
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
David M Kranz
Co-authored papers 3
Laura Menocal
Weill Graduate School of Medical Sciences of Cornell University
Co-authored papers 3
Nicholas D Socci
Co-authored papers 3
Jeffrey J Delrow
Clinical Research Division, Fred Hutchinson Cancer Research Center
Co-authored papers 2
Richard Koche
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Mohita Tagore
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Fiona Ginty
GE Global Research Center
Co-authored papers 1
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Elizabeth McDonough
GE Research Center
Co-authored papers 1
Ritika Kundra
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Daniel W Kelly
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Jianjiong Gao
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Christina S Leslie
Co-authored papers 1
Michael S Glickman
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Ido Amit
Weizmann Institute of Science
Co-authored papers 1
Timothy A Chan
Cleveland Clinic.
Co-authored papers 1
Stephanie Melendez
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Lars Zender
Co-authored papers 1
Jennifer A Wargo
Co-authored papers 1
Arnab Ghosh
Co-authored papers 1
John M Kirkwood
UPMC Hillman Cancer Center
Co-authored papers 1
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Ankit Sinha
Max Planck Institute of Biochemistry
Co-authored papers 1
J??r??mie Nsengimana
Population Health Sciences Institute, Newcastle University
Co-authored papers 1
Asim Dave
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Lora H Ellenson
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Lorenz Studer
The Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Release 1.2